SCHEMBL3846869

SCHEMBL3846869

Fc1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2-c2ccc3ncnc(-c4ccccn4)c3c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 6/20 0.35
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
MTOR P42345 1/20 0.35
PIK3CG P48736 1/20 0.35
THRB P10828 1/20 0.35
MAP4K4 O95819 3/20 0.34
CSNK1D P48730 3/20 0.33
CSNK1E P49674 3/20 0.33
DYRK1A Q13627 2/20 0.33
EGFR P00533 1/20 0.33
FRK P42685 1/20 0.33
MAPK9 P45984 1/20 0.33
CSNK1A1 P48729 1/20 0.33
GRM5 P41594 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
HPGD P15428 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3847727 0.91 PIK3CD (0.41) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3852071 0.88 MAPK14 (0.36) TGFBR1PIK3CATHRBMAP4K4CSNK1D
SCHEMBL3850507 0.84 MAP4K4 (0.37) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3849617 0.84 PIK3CD (0.36) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3855586 0.84 LMNA (0.39) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3850673 0.83 AURKB (0.36) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL3846871 0.83 THRB (0.33) THRB
SCHEMBL3848456 0.83 PTGS2 (0.46) MAPK14
SCHEMBL3850268 0.83 PTGS2 (0.46) MAPK14
SCHEMBL3847570 0.81 PIK3CD (0.32) PIK3CDPIK3CAPIK3CBMTORPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed